Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph phase_2
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 22 (66.7%)
Phase 31 (33.3%)

Trials by Status

recruiting267%
suspended133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingphase_2

Sonlicromanol in Post-COVID

NCT07298005
recruitingphase_3

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

NCT06451757
suspendedphase_2

The KHENERGYC Study

NCT04846036

Clinical Trials (3)

Showing 3 of 3 trials
NCT07298005Phase 2

Sonlicromanol in Post-COVID

Recruiting
NCT06451757Phase 3

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Recruiting
NCT04846036Phase 2

The KHENERGYC Study

Suspended

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3